The use of nevirapine to prevent mother-to-child transmission (MTCT) of HIV in South Africa has come under threat after reports last week of irregularities during trials of the drug in Uganda.
Links
[1] https://www.pambazuka.org/author/contributor
[2] https://www.pambazuka.org/taxonomy/term/3286
[3] https://www.pambazuka.org/article-issue/59
[4] https://www.pambazuka.org/taxonomy/term/3285
[5] http://www.pambazuka.org/en/category.php/hivaids/6733
[6] https://www.pambazuka.org/taxonomy/term/3287